May 09, 2019
Marker Therapeutics Reports First Quarter 2019 Operating and Financial Results
May 07, 2019
Marker Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
Mar 28, 2019
Marker Therapeutics Provides Business and Clinical Update
Mar 18, 2019
Marker Therapeutics to Host Business Update Conference Call and Webcast on Thursday, March 28th
Feb 25, 2019
Marker Therapeutics Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019
Feb 21, 2019
Marker Therapeutics Congratulates Helen E. Heslop, MD, DSc (Hon) on Receiving the ASBMT Lifetime Achievement Award
Feb 20, 2019
Marker Therapeutics to Present at the CAR-TCR Summit Europe
Feb 07, 2019
Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development
Feb 06, 2019
Marker Therapeutics to Present at the 2019 BIO CEO & Investor Conference
Jan 17, 2019
Marker Therapeutics to Present at the Phacilitate Leaders World & World Stem Cell Summit 2019
Jan 15, 2019
The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019
Dec 06, 2018
Marker Therapeutics to Present at the Tumor Targeted Lymphocytes Summit
Nov 27, 2018
The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the 60th American Society of Hematology Annual Meeting
Nov 27, 2018
Marker Therapeutics, Inc. Appoints Anthony H. Kim as Chief Financial Officer
Nov 08, 2018
Marker Therapeutics to Present at Three Upcoming Healthcare Conferences
Oct 18, 2018
Marker to Present at Two Upcoming Cellular Therapy Conferences
Oct 17, 2018
TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing
May 15, 2018
TapImmune to Host Investor Breakfast to Discuss Proposed Merger with Marker Therapeutics
May 15, 2018
TapImmune and Marker Therapeutics Announce Entry into Merger Agreement, Creating a Transformational Immuno-Oncology Platform